Reaktionsgleichung
[O:1]=[C:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:16]=[CH:15][C:11]([C:12]([OH:14])=O)=[CH:10][CH:9]=2)[CH2:4][CH2:3]1.Cl.[CH2:18]([O:20][C:21](=[O:25])[CH2:22][CH2:23][NH2:24])[CH3:19]>>[CH2:18]([O:20][C:21](=[O:25])[CH2:22][CH2:23][NH:24][C:12](=[O:14])[C:11]1[CH:10]=[CH:9][C:8]([N:5]2[CH2:4][CH2:3][C:2](=[O:1])[CH2:7][CH2:6]2)=[CH:16][CH:15]=1)[CH3:19]Komponenten
3
Versuchsvorschrift
The title compound was prepared from 4-(4-oxo-piperidine-1-yl)-benzoic acid (which was obtained in Example 151) and beta-alanine ethyl ester hydrochloride according to the procedure of Example 154 as a yellowish solid; 1H NMR (300 MHz, CDCl3) δ 1.28 (t, J=7.1 Hz, 3H), 2.56 (t, J=6.1 Hz, 4H), 2.64 (t, J=5.7 Hz, 2H), 3.55-3.65 (m, 6H), 4.15 (q, J=7.1 Hz, 2H), 6.82 (t, J=5.7 Hz, 1H), 6.95 (d, J=8.9 Hz, 2H), 7.70 (d, J=8.9 Hz, 2H); MS (ES) m/z: 319.1 (MH+).
Quellen und Nachweise
- ORD-Eintrag
- ord-fcda06f58c614cc684fa2cc5f03605f6
- Quelldatensatz
- uspto-grants-2003_02
- Patentnummer
- US06525202B2
Verknüpfte Notizen
Wird geladen…